Moderna, Merck See Promise in Experimental Skin Cancer Vaccine​Moderna, Merck See Promise in Experimental Skin Cancer Vaccine 

 Pharmaceutical giants Moderna and Merck say an experimental vaccine treatment for melanoma has shown signs of preventing the skin cancer from returning or spreading. The FDA has not yet approved the vaccine. The agency will review the full data once it has been submitted.  ​​Pharmaceutical giants Moderna and Merck say an experimental vaccine treatment for melanoma has shown signs of preventing the skin cancer from returning or spreading. The FDA has not yet approved the vaccine. The agency will review the full data once it has been submitted.